These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6600077)

  • 1. [Urinary excretion of catecholamines in patients with Graves-Basedow disease and hyperactive nodular goiter before and after treatment with propranolol].
    Mieczkowska J
    Ann Univ Mariae Curie Sklodowska Med; 1983; 38():307-14. PubMed ID: 6600077
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparison of adrenergic activity in Graves-Basedow disease and in nodular goiter].
    Sodolski W; Hanzlik J; Mieczkowska J; Stelmasiak T; Zelazowska A
    Wiad Lek; 1990 Feb 1-15; 43(3-4):96-100. PubMed ID: 2368399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary excretion of free catecholamines in Graves' disease.
    Bayliss RI; Edwards OM
    J Endocrinol; 1971 Jan; 49(1):167-73. PubMed ID: 5108819
    [No Abstract]   [Full Text] [Related]  

  • 4. Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements.
    Berg GE; Michanek AM; Holmberg EC; Fink M
    J Nucl Med; 1996 Feb; 37(2):228-32. PubMed ID: 8667049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of propranolol on levels of thyroxine and triliodothyronine in hyperthyreotic patients.
    Roszkowska K; Nauman J; Nauman A
    Mater Med Pol; 1974; 6(3):178-82. PubMed ID: 4479974
    [No Abstract]   [Full Text] [Related]  

  • 6. Urinary glycosaminoglycans in Graves' ophthalmopathy.
    Kahaly G; Schuler M; Sewell AC; Bernhard G; Beyer J; Krause U
    Clin Endocrinol (Oxf); 1990 Jul; 33(1):35-44. PubMed ID: 2401097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Increased urinary excretion of neopterin in patients with Graves-Basedow disease].
    Schreiber V; Tomsová Z; Límanová Z; Jůzová Z
    Cas Lek Cesk; 1989 Jul; 128(28):883-4. PubMed ID: 2790883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Surgery of toxic goiter during propranolol therapy].
    Jørgensen JV; Olsen CR; Clementsen HJ; Guldhammer BH; Bruun E
    Ugeskr Laeger; 1982 Feb; 144(5):312-5. PubMed ID: 7041384
    [No Abstract]   [Full Text] [Related]  

  • 9. Jod-Basedow hyperthyroidism with unusual clinical manifestations.
    Wright DL; Burns TW
    Mo Med; 1985 Oct; 82(10):647-50. PubMed ID: 3840569
    [No Abstract]   [Full Text] [Related]  

  • 10. [Development of Basedow disease after radioiodine therapy for nodular goiter].
    Cseke B; Balázs C
    Orv Hetil; 2003 Nov; 144(47):2327-9. PubMed ID: 14725052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Bcl-2 family proteins in thyrocytes from young patients with immune and nonimmune thyroid diseases.
    Bossowski A; Czarnocka B; Bardadin K; Urban M; Niedziela M; Dadan J
    Horm Res; 2008; 70(3):155-64. PubMed ID: 18663316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical evaluation of basal secretion and secretory function of the gastric mucosa in hyperactive nodular goiter and Graves-Basedow disease].
    Cichoń S
    Folia Med Cracov; 1976; 18(2):253-71. PubMed ID: 946600
    [No Abstract]   [Full Text] [Related]  

  • 13. [Goiter size and prognosis of thyrotoxicosis treated medically].
    Laurberg P; Hansen PE; Iversen E; Jensen SE; Weeke J
    Ugeskr Laeger; 1987 May; 149(20):1325-7. PubMed ID: 3603777
    [No Abstract]   [Full Text] [Related]  

  • 14. [The treatment of toxic multinodular goiter].
    Fagel WJ; van der Vijver JC
    Ned Tijdschr Geneeskd; 1987 Feb; 131(6):252-3. PubMed ID: 2436063
    [No Abstract]   [Full Text] [Related]  

  • 15. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
    Franklyn JA; Daykin J; Holder R; Sheppard MC
    QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of reserpine on blood lipid and urine catecholamine levels in patients with diffuse toxic goiter].
    Baranov VG; Zaripova ZKh; Slobodskoĭ VR; Ugoleva SV
    Ter Arkh; 1971 Jul; 43(7):98-102. PubMed ID: 5172576
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical aspects, diagnosis and drug therapy of hyperthyroidism].
    Bürgi U; Gerber H; Peter HJ
    Schweiz Med Wochenschr; 1995 Aug; 125(31-32):1489-94. PubMed ID: 7545825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of lithium carbonate in the preparation for definitive therapy in hyperthyroid patients.
    Akin F; Yaylali GF; Bastemir M
    Med Princ Pract; 2008; 17(2):167-70. PubMed ID: 18287805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A comparative assessment of the efficacy of antithyroid therapy in patients with nodular and diffuse toxic goiter].
    Alesov VZ
    Probl Endokrinol (Mosk); 1976; 22(1):12-5. PubMed ID: 946555
    [No Abstract]   [Full Text] [Related]  

  • 20. [Sympathetic-adrenal system in ischemic heart disease before and after obzidan treatment].
    Orlov VN; Chigrinova LS
    Klin Med (Mosk); 1981 Jun; 59(6):74-8. PubMed ID: 6116820
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.